SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-303004
Filing Date
2023-12-26
Accepted
2023-12-26 16:02:01
Documents
12
Period of Report
2023-12-22
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K d620772d8k.htm   iXBRL 8-K 25554
  Complete submission text file 0001193125-23-303004.txt   151119

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vera-20231222.xsd EX-101.SCH 2837
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vera-20231222_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vera-20231222_pre.xml EX-101.PRE 11699
6 EXTRACTED XBRL INSTANCE DOCUMENT d620772d8k_htm.xml XML 3479
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 231513322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)